Effects of Bisphosphonates on the Proliferation and the Alkaline Phosphatase Activity of Human Bone Marrow Derived Mesenchymal Stem Cells

Junho JUNG; Baeksoo LEE; Yong-Dae KWON; Joo-Young OHE; Young-Ran KIM.
Journal of the Korean Association of Maxillofacial Plastic and Reconstructive Surgeons ; : 10-18, 2011.
Artículo en Ko | WPRIM | ID: wpr-785047

Documentos relacionados

  1. Recognizing bisphosphonate-induced ear osteonecrosis in primary care: a case report.
  2. Medication-related osteonecrosis of the jaw (MRONJ): a review of pathogenesis hypothesis and therapy strategies.
  3. Medication-related osteonecrosis of the jaw: Osteoclast profile in comparison with osteoradionecrosis of the jaw and osteomyelitis of the jaw.
  4. Medication-Related Osteonecrosis of the Jaw: 14 Years' Retrospective Study on Pathogenetic Trigger Events.
  5. [Application of double-layer soft tissue suture closure technique in the surgical treatment of patients with mandible medication-related osteonecrosis of the jaw of early and medium stages].
  6. Semaphorin 4D Promotes Osteoclast Formation but Inhibits Osteoblast Formation: Implication in Bisphosphonate-Related Osteonecrosis of the Jaw.
  7. Bone turnover markers can predict healing time in medication-related osteonecrosis of the jaw.
  8. Evaluation of Medication-Related Osteonecrosis of the Jaw (MRONJ) in Terms of Staging and Treatment Strategies by Dental Students at Different Educational Levels.
  9. Borate bioactive glass prevents zoledronate-induced osteonecrosis of the jaw by restoring osteogenesis and angiogenesis.
  10. Endothelial progenitors increase vascularization and improve fibroblasts function that prevent medication-related osteonecrosis of the jaw.